BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Tiotropium Respimat Pharmacokinetic Study in COPD
- Status
- COMPLETED
- Phase
- PHASE2
Telmisartan 80mg Non-responder Trial
- Status
- COMPLETED
- Phase
- PHASE3
Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy
- Status
- COMPLETED
- Phase
- PHASE3
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
LUX Lung Special Access Scheme Australia Named Patient Use (NPU)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee
- Status
- TERMINATED
- Phase
- PHASE1
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Comprehensive Add on Study in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1